Systemic Inflammation Response Index and C-Reactive Protein to Albumin Ratio in Acute Lymphoblastic Leukemia

Biomarkers That Predict Response to High-Dose Aldesleukin in Metastatic Kidney Cancer or Metastatic Melanoma

NCT00617799 ·Status: COMPLETED

Prospective and Retrospective Cohort Study to Find New Prognostic Factors and Therapeutic Targets in Patients With Newly Diagnosed or Relapsed Malignant Hematologic Disorder Excluding Acute Leukemia

NCT02330718 ·Status: UNKNOWN

New Serum Biomarkers for Monitoring Early Diagnosis of Ovarian Cancer Recurrence

NCT05410028 ·Status: RECRUITING

Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy

NCT00349830 ·Status: RECRUITING

Clinico-hematological and Molecular Characteristics of Chronic Lymphocytic Leukemia Patients

NCT07162532 ·Status: NOT_YET_RECRUITING

Role of Biomarkers in Disease Progression in Samples From Patients With Acute Myeloid Leukemia

NCT01500499 ·Status: COMPLETED

Detection of Plasmatic Cell-free BRAF and NRAS Mutations : a New Tool for Monitoring Patients with Metastatic Malignant Melanoma Treated with Targeted Therapies or Immunotherapy ( MALT )

NCT03493230 ·Status: COMPLETED ·Phase: NA

Augsburg Longitudinal Plasma Study for the Evaluation of Liquid Biopsy as Diagnostic Tool.

NCT05245136 ·Status: RECRUITING

Analysis of Circulating Tumor Markers in the Blood (ALCINA)

NCT02866149 ·Status: COMPLETED ·Phase: NA

Biomarker Expression in Samples From Young Patients With Anaplastic Large Cell Lymphoma

NCT01366170 ·Status: COMPLETED

Biomarkers in DNA Samples From Patients With High-Risk Acute Lymphoblastic Leukemia

NCT01119586 ·Status: COMPLETED

Non-invasive Liquid Biopsy Analysis of Epigenomics Signatures in Multiple Cancer Types

NCT03869814 ·Status: RECRUITING

Blood and Tumor Tissue Samples From Young Patients With Acute Myeloid Leukemia

NCT01139333 ·Status: COMPLETED

Genome Wide SNP Array-based Approach to Detect Micro-cytogenetic Lesions and KIT Mutation to Improve Treatment Outcomes in Patients With Core-binding Factor Positive Acute Myeloid Leukemia

NCT01066286 ·Status: UNKNOWN

Analyzing the Composition of Tears and Blood for Discovery of Novel Signatures of Aggressive Prostate Cancer

NCT01514669 ·Status: ACTIVE_NOT_RECRUITING

Multi-omics Approach of Risk Stratification for Patients With de Novo Acute Myeloid Leukemia

NCT05983172 ·Status: ENROLLING_BY_INVITATION

UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer

NCT00900094 ·Status: COMPLETED

Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia

NCT01005368 ·Status: COMPLETED

Identification of Key Blood Molecular Markers for Immunotherapy

NCT00507702 ·Status: TERMINATED

Studying Biomarkers in Tumor Tissue and Blood Samples From Patients With Small Cell Lung Cancer Registered on CALGB-140202

NCT01503619 ·Status: COMPLETED

Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs

NCT04985357 ·Status: WITHDRAWN

Immunophenotyping in Metastatic Kidney Cancer Patients Receiving Ablative Therapy

NCT05112627 ·Status: COMPLETED

S8600-S9031-S9333-A, Study of DNA in Samples From Patients With Acute Myeloid Leukemia

NCT01434329 ·Status: COMPLETED

Studying RNA in Samples From Younger Patients With T-Cell Acute Lymphoblastic Leukemia

NCT01626183 ·Status: COMPLETED

Myeloid Mutations Register in R/R CML

NCT05080829 ·Status: UNKNOWN ·Phase: NA